Elocon vs Fluticasone in Localized Psoriasis (P03197)

Inclusion Criteria: * \>=18 years of age * Written informed consent * Having localized psoriasis (not more than 5-6 patches) * Total size of all patches should be below 8" x 8" * Each patient should exhibit any of the following 4 signs of dermatoses: * erythema * palpability * scaling * itching (pruritus) Each of the above signs would be grades according to the following scale: 0 = none 1. = slight 2. = moderate 3. = severe The total Disease Severity Score (ie, the sum of the scores for each of the signs) should be at least 6 (indicative of a moderate to severe disease status) Exclusion Criteria: * Pregnancy or lactation * Hypersensitivity to any of the components of the test medication * Signs of atrophy in the target area * Lesions on palms, soles, and scalp * Individuals who may require medications that might affect the natural course of the disease * Not having used systemic corticosteroids or antimetabolites or any other topical corticosteroid within 2 weeks prior to enrollment in the study * Concomitant tuberculosis/viral infection